272 related articles for article (PubMed ID: 34843456)
1. Protein domain-based prediction of drug/compound-target interactions and experimental validation on LIM kinases.
Doğan T; Akhan Güzelcan E; Baumann M; Koyas A; Atas H; Baxendale IR; Martin M; Cetin-Atalay R
PLoS Comput Biol; 2021 Nov; 17(11):e1009171. PubMed ID: 34843456
[TBL] [Abstract][Full Text] [Related]
2. A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1.
Prudent R; Demoncheaux N; Diemer H; Collin-Faure V; Kapur R; Paublant F; Lafanechère L; Cianférani S; Rabilloud T
PLoS One; 2018; 13(12):e0208979. PubMed ID: 30550596
[TBL] [Abstract][Full Text] [Related]
3. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation.
Mardilovich K; Gabrielsen M; McGarry L; Orange C; Patel R; Shanks E; Edwards J; Olson MF
Mol Cancer Ther; 2015 Jan; 14(1):246-58. PubMed ID: 25344584
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization.
Champiré A; Berabez R; Braka A; Cosson A; Corret J; Girardin C; Serrano A; Aci-Sèche S; Bonnet P; Josselin B; Brindeau P; Ruchaud S; Leguevel R; Chatterjee D; Mathea S; Knapp S; Brion R; Verrecchia F; Vallée B; Plé K; Bénédetti H; Routier S
Eur J Med Chem; 2024 May; 271():116391. PubMed ID: 38669909
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cofilin phosphorylation by inhibition of the Lim family kinases.
He L; Seitz SP; Trainor GL; Tortolani D; Vaccaro W; Poss M; Tarby CM; Tokarski JS; Penhallow B; Hung CY; Attar R; Lin TA
Bioorg Med Chem Lett; 2012 Sep; 22(18):5995-8. PubMed ID: 22902653
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.
Yi F; Guo J; Dabbagh D; Spear M; He S; Kehn-Hall K; Fontenot J; Yin Y; Bibian M; Park CM; Zheng K; Park HJ; Soloveva V; Gharaibeh D; Retterer C; Zamani R; Pitt ML; Naughton J; Jiang Y; Shang H; Hakami RM; Ling B; Young JAT; Bavari S; Xu X; Feng Y; Wu Y
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381571
[TBL] [Abstract][Full Text] [Related]
7. Targeting ROCK/LIMK/cofilin signaling pathway in cancer.
Lee MH; Kundu JK; Chae JI; Shim JH
Arch Pharm Res; 2019 Jun; 42(6):481-491. PubMed ID: 31030376
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput screening method for LIM kinase 1 using a luciferase-based assay of ATP consumption.
Mezna M; Wong AC; Ainger M; Scott RW; Hammonds T; Olson MF
J Biomol Screen; 2012 Apr; 17(4):460-8. PubMed ID: 22156225
[TBL] [Abstract][Full Text] [Related]
9. LIM Kinases, Promising but Reluctant Therapeutic Targets: Chemistry and Preclinical Validation In Vivo.
Berabez R; Routier S; Bénédetti H; Plé K; Vallée B
Cells; 2022 Jun; 11(13):. PubMed ID: 35805176
[TBL] [Abstract][Full Text] [Related]
10. LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation.
Mardilovich K; Baugh M; Crighton D; Kowalczyk D; Gabrielsen M; Munro J; Croft DR; Lourenco F; James D; Kalna G; McGarry L; Rath O; Shanks E; Garnett MJ; McDermott U; Brookfield J; Charles M; Hammonds T; Olson MF
Oncotarget; 2015 Nov; 6(36):38469-86. PubMed ID: 26540348
[TBL] [Abstract][Full Text] [Related]
11. Structural Aspects of LIMK Regulation and Pharmacology.
Chatterjee D; Preuss F; Dederer V; Knapp S; Mathea S
Cells; 2022 Jan; 11(1):. PubMed ID: 35011704
[TBL] [Abstract][Full Text] [Related]
12. Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.
Mashiach-Farkash E; Rak R; Elad-Sfadia G; Haklai R; Carmeli S; Kloog Y; Wolfson HJ
Oncotarget; 2012 Jun; 3(6):629-39. PubMed ID: 22776759
[TBL] [Abstract][Full Text] [Related]
13. LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice.
Li R; Doherty J; Antonipillai J; Chen S; Devlin M; Visser K; Baell J; Street I; Anderson RL; Bernard O
Clin Exp Metastasis; 2013 Apr; 30(4):483-95. PubMed ID: 23239465
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity.
Collins R; Lee H; Jones DH; Elkins JM; Gillespie JA; Thomas C; Baldwin AG; Jones K; Waters L; Paine M; Atack JR; Ward SE; Grubisha O; Foley DW
J Med Chem; 2022 Oct; 65(20):13705-13713. PubMed ID: 36205722
[TBL] [Abstract][Full Text] [Related]
15. Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors.
Yin Y; Zheng K; Eid N; Howard S; Jeong JH; Yi F; Guo J; Park CM; Bibian M; Wu W; Hernandez P; Park H; Wu Y; Luo JL; LoGrasso PV; Feng Y
J Med Chem; 2015 Feb; 58(4):1846-61. PubMed ID: 25621531
[TBL] [Abstract][Full Text] [Related]
16. Damnacanthal, an effective inhibitor of LIM-kinase, inhibits cell migration and invasion.
Ohashi K; Sampei K; Nakagawa M; Uchiumi N; Amanuma T; Aiba S; Oikawa M; Mizuno K
Mol Biol Cell; 2014 Mar; 25(6):828-40. PubMed ID: 24478456
[TBL] [Abstract][Full Text] [Related]
17. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators.
Manetti F
Med Res Rev; 2012 Sep; 32(5):968-98. PubMed ID: 22886629
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase.
Horita Y; Ohashi K; Mukai M; Inoue M; Mizuno K
J Biol Chem; 2008 Mar; 283(10):6013-21. PubMed ID: 18171679
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.
Yu Q; Gratzke C; Wang Y; Herlemann A; Sterr CM; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Stief CG; Hennenberg M
Br J Pharmacol; 2018 Jun; 175(11):2077-2096. PubMed ID: 29574791
[TBL] [Abstract][Full Text] [Related]
20. Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells.
Djamai H; Berrou J; Dupont M; Kaci A; Ehlert JE; Weber H; Baruchel A; Paublant F; Prudent R; Gardin C; Dombret H; Braun T
Leuk Res; 2021 Jan; 100():106490. PubMed ID: 33373830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
